NSC |
Compound |
Enrichment |
Correlation |
NSC 740504 |
5,6-Dihydro-6-[3-(2-hydroxyethyl)amino-1-propyl]-3-nitro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride |
0.0459335986102865 |
0.079905356 |
NSC 741412 |
4-(5'-bromofuran-2'-yl)-3-bromo-but-3-en-2-one |
0.0459335986102865 |
0.39273032 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0474314077111075 |
0.051156864 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0474314077111075 |
0.14686636 |
NSC 253272 |
Acetamide, N-[(methylamino)carbonyl]-N-[[(methylamino)carbonyl]oxy]- (9CI) |
0.0474314077111082 |
0.47302699 |
NSC 668490 |
Null |
0.0474314077111082 |
0.067006381 |
NSC 672120 |
Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer |
0.0474314077111082 |
0.25365287 |
NSC 686393 |
Null |
0.0474314077111082 |
0.092880871 |
NSC 19441 |
FDA 0283 |
0.048939380959983 |
0.06379523 |
NSC 210717 |
Ellipticine, 9-hydroxy-, hydrochloride |
0.048939380959983 |
0.19787729 |